Verapamil Hydrochloride Tablet
FDA Label NDC 70771-1955

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Verapamil Hydrochloride (NDC 70771-1955). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

Package Label.Principal Display Panel

NDC 70771-1953-1 in bottles of 100 tablets

Verapamil Hydrochloride Extended-Release Tablets, USP 120 mg

100 Tablets

Rx Only

Image (75856e69 15d6 4982 895a 2c9e76e8020f 01)

Image (75856e69 15d6 4982 895a 2c9e76e8020f 01)

NDC 70771-1954-1 in bottles of 100 tablets

Verapamil Hydrochloride Extended-Release Tablets, USP 180 mg

100 Tablets

Rx Only

Image (75856e69 15d6 4982 895a 2c9e76e8020f 02)

Image (75856e69 15d6 4982 895a 2c9e76e8020f 02)

NDC 70771-1955-1 in bottles of 100 tablets

Verapamil Hydrochloride Extended-Release Tablets, USP 240 mg

100 Tablets

Rx Only

Image (75856e69 15d6 4982 895a 2c9e76e8020f 03)

Image (75856e69 15d6 4982 895a 2c9e76e8020f 03)

* Please review the disclaimer below.